Skip to main content
. 2019 Dec 6;2019(12):CD011207. doi: 10.1002/14651858.CD011207.pub2

Cordina 2001.

Methods Design: cluster‐RT
Groups: intervention (asthma education and monitoring); control (routine dispensing services)
Participants Pharmacies: 22 (intervention 11; control 11)
Pharmacy worker: not reported
‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐
Pharmacy user: 152 asthma patients
  • mean age: intervention 41.3 ± 18.35 years; control 45.88 ± 18.11 years

  • % female:intervention 57%; control 39%


Setting: both urban and rural
Country: Malta
Interventions Pharmacy worker‐directed intervention:
A manual was prepared in the form of a self‐study program with 2 sections: Section 1 dealt with the pathophysiology of asthma and its treatment, including standard intervention instructions; Section 2 provided details of outcome measures and data collection instruments to be used in the study.
  • Delivered by: researcher

  • Type: education

  • Mode of delivery: group

  • TDF: knowledge

  • Duration: 2 evenings; first evening open only to the intervention group and focused on the intervention, the second evening was open to both groups and focused on study procedures. No other information was provided.


Pharmacy worker control: only attended second evening and received section 2 of manual
‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐
Pharmacy user‐directed intervention: patients received verbal counselling, an educational video, an information leaflet, and subsequent monitoring with reinforcement.
  • Delivered by: pharmacists

  • Type: self‐management

  • Mode of delivery: individual face‐to‐face; video/DVD; written materials

  • TDF: knowledge, skills, behavioural regulation

  • Duration: unclear

  • Follow up: 12 months (end of intervention)


Pharmacy user control: patients were given their prescribed drugs and informed of the dosage regimen, but received no other assistance.
Outcomes Pharmacy worker: not assessed
‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐
Pharmacy user:
  • Clinical: PEFR

  • Psychological health: not assessed

  • Behavioural: inhaler technique

  • Quality of life: patient's health‐related quality of life Short Form 36 (SF‐36); Living With Asthma Questionnaire (LWAQ) for adults; Childhood Asthma Questionnaire (CAQ) for children aged 14 to 17 years

  • Process: patients' subjective opinions of the services provided obtained through a structured patient satisfaction questionnaire

  • Costs/HCU: hospitalisations, GP visits, days off work

Notes Funding source: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Method of randomisation not stated.
Allocation concealment (selection bias) Low risk Cluster randomised
Baseline outcome measures similar Low risk Some differences, but adjusted for in analysis.
Baseline characteristics similar Low risk Some differences, but adjusted for in analysis.
Incomplete outcome data (attrition bias) 
 All outcomes High risk High dropout and unclear how this was adjusted for.
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Not stated
Protection against contamination Unclear risk Randomisation by pharmacists, but patients came from same asthma clinic.
Selective reporting (reporting bias) Low risk Not noted
Other bias Unclear risk Differences in groups at baseline and attrition may have had significant effect.
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Not stated